Xenetic Biosciences (XBIO) News Today → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free XBIO Stock Alerts $4.27 +0.37 (+9.49%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Xenetic Biosciences Inc (NASDAQ:XBIO) Grows By 64.7%americanbankingnews.com - April 27 at 3:40 AMXenetic Biosciences Inc (XBIO)investing.com - April 10 at 3:28 PMXenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 24 at 5:09 PMXenetic Dips on Full-Year Resultsbaystreet.ca - March 22 at 7:33 PMXenetic Biosciences reports FY resultsmsn.com - March 22 at 8:51 AMXenetic to advance DNase programme with UVA partnershipmsn.com - January 18 at 1:37 PMXenetic Biosciences Inc XBIOmorningstar.com - January 4 at 5:10 PMXenetic Biosciences Stock (NASDAQ:XBIO), Guidance and Forecastbenzinga.com - December 11 at 9:01 AMMost Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensationfinance.yahoo.com - November 30 at 10:39 AMXenetic Biosciences: Q3 Earnings Insightsbenzinga.com - November 10 at 3:38 PMMediciNova: Q3 Earnings Snapshotwashingtonpost.com - November 10 at 10:37 AMXenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conferencefinance.yahoo.com - October 11 at 9:30 AMXenetic Biosciences (XBIO) Upgraded to Strong Buy: What Does It Mean for the Stock?msn.com - July 13 at 1:44 PMmarketbeat.com - July 12 at 1:03 PMmarketbeat.com - July 12 at 12:52 PMmarketbeat.com - July 12 at 12:42 PMmarketbeat.com - May 15 at 10:11 AMmarketbeat.com - May 15 at 10:03 AMmarketbeat.com - May 15 at 9:54 AMmarketbeat.com - May 15 at 9:47 AMXenetic Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 11 at 5:06 PMXenetic Biosciences, Inc. Adds Business Development Expertise with Appointment of Scott N. Cullison | Morningstarmorningstar.com - May 5 at 10:21 AMXenetic Biosciences, Inc. Bolsters R&D and Regulatory Expertise with Appointment of Reid P. Bissonnette, Ph.D. as Executive Consultant for Translational Research and Developmentfinance.yahoo.com - May 4 at 10:02 AMXenetic Biosciences, Inc. Adds Business Development Expertise with Appointment of Scott N. Cullisonfinance.yahoo.com - May 3 at 10:26 AMHC Wainwright & Co. Reiterates Xenetic Biosciences (XBIO) Buy Recommendationmsn.com - April 12 at 10:37 PMAnalysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP) and Xenetic Biosciences (XBIO)markets.businessinsider.com - April 12 at 2:30 AMXenetic Biosciences, Inc. Announces Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platformfinance.yahoo.com - April 11 at 8:43 AMJTC Team, LLC: JTC Team to Host Virtual Investor NETs in Cancer Spotlight Event Featuring Xenetic Biosciencesfinanznachrichten.de - March 16 at 12:09 PMJTC Team to Host Virtual Investor NETs in Cancer Spotlight Event Featuring Xenetic Biosciencesfinance.yahoo.com - March 16 at 12:09 PMXBIO Xenetic Biosciences, Inc.seekingalpha.com - February 23 at 11:29 PMXBIO.PH - | Stock Price & Latest News | Reutersreuters.com - February 21 at 2:09 PMXenetic Biosciences, Inc. Announces Notice of Allowance for Canadian Patent Covering Use of DNase Enzyme for Preventing or Ameliorating Toxicity Associated with Chemotherapyfinance.yahoo.com - January 17 at 12:50 PMWhy We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At Allfinance.yahoo.com - December 15 at 7:15 AMThis Is Why Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Looks Appropriatefinance.yahoo.com - December 1 at 6:22 PMXenetic Biosciences Third Quarter 2022 Earnings: Beats Expectationsfinance.yahoo.com - November 12 at 1:08 PMXenetic Biosciences, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 10:36 AMXenetic Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - August 12 at 8:15 AMXenetic Biosciences, Inc. to Participate in the Virtual Investor Innovation in Oncology Eventfinance.yahoo.com - June 2 at 8:53 AMXenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - May 18 at 2:22 PMXenetic Biosciences reports Q1 resultsseekingalpha.com - May 12 at 5:52 PMXenetic Biosciences, Inc. Reports First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 12 at 5:52 PMHC Wainwright & Co. Maintains Buy on Xenetic Biosciences, Lowers Price Target to $4benzinga.com - May 2 at 11:50 AMXenetic Biosciences expands pipeline with DNase based oncology platform from CLS Therapeuticsproactiveinvestors.com - May 2 at 11:50 AMXenetic stock rises 10% on license deal for CLS Therapeutics' cancer drugs platformseekingalpha.com - April 27 at 8:23 AMXenetic Biosciences, Inc. Expands Oncology Pipeline with In-Licensing of DNase Based Oncology Platform Comprising Multiple Therapeutic Modalitiesfinance.yahoo.com - April 27 at 8:23 AMXenetic Biosciences, Inc. Reports Full Year 2021 Financial Results and Provides Business Update | Morningstarmorningstar.com - March 24 at 9:23 PMXenetic Biosciences GAAP EPS of -$0.55, revenue of $1.16Mseekingalpha.com - March 23 at 10:13 AMXenetic Biosciences, Inc. Reports Full Year 2021 Financial Results and Provides Business Updatefinance.yahoo.com - March 23 at 10:13 AM'We are expanding the potential of CAR T cell therapy through the development of our XCART technology platform...' -Tweet From Xenetic Biosciencesbenzinga.com - December 11 at 12:30 AMXenetic Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Updatefinance.yahoo.com - November 12 at 11:20 AM Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address FW: 234x Gain (Ad)This coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain. Click here. XBIO Media Mentions By Week XBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XBIO News Sentiment▼0.980.43▲Average Medical News Sentiment XBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XBIO Articles This Week▼10▲XBIO Articles Average Week Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LIXT News Today SHPH News Today ENVB News Today HILS News Today TFFP News Today ADIL News Today PULM News Today AIMD News Today PCSA News Today CVKD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XBIO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
